Growing Body of Clinical Evidence Demonstrating Aurix’s Efficacy
Nuo Therapeutics, Inc. (NUOT – $0.26) earlier this week presented new clinical evidence that supports its leading-edge therapies for wound care. The Company’s star product, Aurix is the first platelet and plasma therapy system that’s cleared by the FDA for the management of ulcers and wounds of all types (diabetic foot ulcer, pressure ulcer, venous leg ulcer, etc.) and all […]
Read more